Welcome to our “News” page, your gateway to the most current updates, insights, and exciting developments in the world of ophthalmology and Dr. Gibran Khurshid’s contributions. Stay informed about groundbreaking surgeries, research breakthroughs, global outreach initiatives, and more. Explore the ever-evolving landscape of eye care and the stories that shape our journey towards a brighter, more informed future.
Surgeons from the USA, Europe, and Asia have all traveled to UF to have me train them on this challenging surgical procedure. Furthermore, I have delivered many hands-on surgical courses and given multiple invited lectures in Poland, Australia, Ireland, and the United Kingdom to share and teach my expertise.
As depicted to the right, my accomplishments in the field of artificial vision were covered in Delta airlines inflight magazine. This magazine is available on Delta airlines’ domestic and international flights. For my achievements in artificial vision and my other accomplishments, I was awarded “Best Doctors in America Award” in 2019.
For patients with eye cancer, University of Florida Health ophthalmology specialist Gibran S. Khurshid, M.D., is sowing seeds of hope.
In Khurshid’s case, those seeds are tiny particles of radioactive iodine. Attached to a gold implant about the size of a contact lens, the “seeds” deliver tightly focused radiation to eye cancer, oruveal melanoma. Khurshid, an associate professor in the UF College of Medicine’s department of ophthalmology, began doing the procedures earlier this year.
For patients with eye cancer, University of Florida Health ophthalmology specialist Gibran S. Khurshid, MD, is sowing seeds of hope. In Khurshid’s case, those seeds are tiny particles of radioactive iodine. Attached to a gold implant about the size of a contact lens, the “seeds” deliver tightly focused radiation to eye cancer, oruveal melanoma, according to an announcement issued by the University. Khurshid, an associate professor in the UF College of Medicine’s department of ophthalmology, began doing the procedures earlier this year. The implant, known as a radioactive iodine plaque, is sewn onto the surface of the eye. It stays there for four days, delivering precise doses of radiation to the cancer.
Explore the Journey of a Distinguished Ophthalmologist
Dr. Gibran Khurshid holds full medical licenses in several countries, including the USA (Florida, New York, and Texas), Ireland, the United Kingdom, and Australia. These licenses have been maintained since 1996 and are current as of the present year.
Dr. Gibran Khurshid’s extensive education and training include a Bachelor of Medicine and Surgery (MBBS) from King Edward Medical University, Lahore, Pakistan, in 1994.
Dr. Gibran Khurshid has made significant contributions to the field of ophthalmology, particularly at the University of Florida. He established and directed a state-of-the-art vitreoretinal service, introduced pediatric retina and ocular oncology services, and conducted innovative research. His expertise extends to implanting the “bionic eye” and managing electrodiagnostic services. Dr. Khurshid is also actively involved in various committees and educational initiatives, showcasing his commitment to academic excellence and innovation in the field.
Dr. Gibran Khurshid has made significant contributions to the field of ophthalmology, particularly at the University of Florida. He established and directed a state-of-the-art vitreoretinal service, introduced pediatric retina and ocular oncology services, and conducted innovative research. His expertise extends to implanting the “bionic eye” and managing electrodiagnostic services. Dr. Khurshid is also actively involved in various committees and educational initiatives, showcasing his commitment to academic excellence and innovation in the field.
Disclaimer: The information provided on this website is for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional for personalized medical guidance.